Blog

Dec 7, 2024, 10:47

Rational CAR design for augmented T cell function – Journal for ImmunoTherapy of Cancer

Journal for ImmunoTherapy of Cancer shared the following on X:

“New JITC article: Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.”

Rational CAR design for augmented T cell function - Journal for ImmunoTherapy of Cancer

Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function

Authors: Markus Barden, Patrick Ronan Elsenbroich, Vivian Haas, Moritz Ertelt, Philip Pervan, Lukas Velas, Bence Gergely, Árpád Szöőr, Dennis Christoph Harrer, Valerie Bezler, Astrid Holzinger, Rasmus Ulslev Wegener Friis, Gyorgy Vereb, Gerhard J Schütz, Clara T Schoeder, Andreas A Hombach, Hinrich Abken

Rational CAR design for augmented T cell function - Journal for ImmunoTherapy of Cancer

advanced therapies cancer Cancer research cancer treatment advancements CAR design CAR-T cell engineering immune responses immunotherapy Journal for ImmunoTherapy of Cancer OncoDaily Oncology Oncology Innovation T cell function

Meet the New AACR Board of Directores for 2025-2028 Term

Do Artificial Sweeteners Cause Cancer? Myths and Facts

King Charles III Hospitalized Following Side Effects from Cancer Treatment

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris